{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:05:02Z","timestamp":1742789102381,"version":"3.40.2"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12033-024-01142-5","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:01:47Z","timestamp":1713286907000},"page":"1321-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases"],"prefix":"10.1007","volume":"67","author":[{"given":"Dilara","family":"Aylar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-470X","authenticated-orcid":false,"given":"Ayse","family":"Karatug Kacar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-018-0088-0","volume":"557","author":"Q Zhou","year":"2018","unstructured":"Zhou, Q., & Melton, D. A. (2018). Pancreas regeneration. Nature, 557, 351\u2013358.","journal-title":"Nature"},{"key":"1142_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","volume":"19","author":"T Okabayashi","year":"2013","unstructured":"Okabayashi, T., Shima, Y., Sumiyoshi, T., Kozuki, A., Ito, S., Ogawa, Y., Kobayashi, M., & Hanazaki, K. (2013). Diagnosis and management of insulinoma. World Journal of Gastroenterology, 19, 829\u2013837.","journal-title":"World Journal of Gastroenterology"},{"key":"1142_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","volume":"12","author":"P Sarantis","year":"2020","unstructured":"Sarantis, P., Koustas, E., Papadimitropoulou, A., Papavassiliou, A. G., & Karamouzis, M. V. (2020). Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World Journal of Gastrointestinal Oncology, 12, 173\u2013181.","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"1142_CR4","doi-asserted-by":"crossref","unstructured":"Walkowska, J., Zielinska N., Karauda P., Tubbs R.S., Kurtys K., & Olewnik \u0141. (2022) The pancreas and known factors of acute pancreatitis. Journal of Clinical Medicine 11.","DOI":"10.3390\/jcm11195565"},{"issue":"Suppl 1","key":"1142_CR5","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, 33(Suppl 1), S62\u2013S69.","journal-title":"Diabetes Care"},{"key":"1142_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/molecules25081987","volume":"25","author":"A Artasensi","year":"2020","unstructured":"Artasensi, A., Pedretti, A., Vistoli, G., & Fumagalli, L. (2020). Type 2 diabetes mellitus: A review of multi-target drugs. Molecules, 25, 8.","journal-title":"Molecules"},{"key":"1142_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/08977194.2019.1652400","volume":"37","author":"N Kaddour","year":"2019","unstructured":"Kaddour, N., Zhang, D., Gao, Z. H., & Liu, J. L. (2019). Recombinant protein CCN5\/WISP2 promotes islet cell proliferation and survival in vitro. Growth Factors, 37, 120\u2013130.","journal-title":"Growth Factors"},{"key":"1142_CR8","doi-asserted-by":"publisher","first-page":"104716","DOI":"10.1016\/j.phrs.2020.104716","volume":"155","author":"H Dianat-Moghadam","year":"2020","unstructured":"Dianat-Moghadam, H., Heidarifard, M., Mahari, A., Shahgolzari, M., Keshavarz, M., Nouri, M., & Amoozgar, Z. (2020). TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies. Pharmacological Research, 155, 104716.","journal-title":"Pharmacological Research"},{"key":"1142_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13402-016-0274-8","volume":"39","author":"AW Tseng","year":"2016","unstructured":"Tseng, A. W., Chen, C., Breslin, M. B., & Lan, M. S. (2016). Tumor-specific promoter-driven adenoviral therapy for insulinoma. Cellular Oncology (Dordrecht), 39, 279\u2013286.","journal-title":"Cellular Oncology (Dordrecht)"},{"key":"1142_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/hyb.1983.2.69","volume":"2","author":"K Shimizu","year":"1983","unstructured":"Shimizu, K., Reintgen, D., Rowley, R., Coleman, E., Briner, W., Seigler, H., & Eisenbarth, G. S. (1983). In vivo and in vitro binding of iodinated monoclonal antibody A2B5 to RIN insulinoma cells. Hybridoma, 2, 69\u201377.","journal-title":"Hybridoma"},{"key":"1142_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/BF00400250","volume":"35","author":"B Ziegler","year":"1992","unstructured":"Ziegler, B., Lucke, S., K\u00f6hler, E., Hehmke, B., Schlosser, M., Witt, S., Besch, W., & Ziegler, M. (1992). Monoclonal antibody-mediated cytotoxicity against rat beta cells detected in vitro does not cause beta-cell destruction in vivo. Diabetologia, 35, 608\u2013613.","journal-title":"Diabetologia"},{"key":"1142_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44178-023-00026-z","volume":"2","author":"A KaratugKacar","year":"2023","unstructured":"KaratugKacar, A., & Ad\u0131guzel, Z. (2023). Dinutuximab beta-targeted therapy kills beta-cell tumors of the pancreas. Holistic Integrative Oncology, 2, 3.","journal-title":"Holistic Integrative Oncology"},{"key":"1142_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jcp.29835","volume":"236","author":"R Wang","year":"2021","unstructured":"Wang, R., & Hu, W. (2021). Asprosin promotes \u03b2-cell apoptosis by inhibiting the autophagy of \u03b2-cell via AMPK-mTOR pathway. Journal of Cellular Physiology, 236, 215\u2013221.","journal-title":"Journal of Cellular Physiology"},{"key":"1142_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00000658-200105000-00002","volume":"233","author":"TA Tirone","year":"2001","unstructured":"Tirone, T. A., Fagan, S. P., Templeton, N. S., Wang, X., & Brunicardi, F. C. (2001). Insulinoma-induced hypoglycemic death in mice is prevented with beta cell-specific gene therapy. Annals of Surgery, 233, 603\u2013611.","journal-title":"Annals of Surgery"},{"key":"1142_CR15","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/hmg\/ddx097","volume":"26","author":"GY Kim","year":"2017","unstructured":"Kim, G. Y., Kwon, J. H., Cho, J. H., Zhang, L., Mansfield, B. C., & Chou, J. Y. (2017). Downregulation of pathways implicated in liver inflammation and tumorigenesis of glycogen storage disease type Ia mice receiving gene therapy. Human Molecular Genetics, 26, 1890\u20131899.","journal-title":"Human Molecular Genetics"},{"key":"1142_CR16","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1172\/JCI58447","volume":"121","author":"P Ravassard","year":"2011","unstructured":"Ravassard, P., Hazhouz, Y., Pechberty, S., Bricout-Neveu, E., Armanet, M., Czernichow, P., & Scharfmann, R. (2011). A genetically engineered human pancreatic \u03b2 cell line exhibiting glucose-inducible insulin secretion. The Journal of Clinical Investigation, 121, 3589\u20133597.","journal-title":"The Journal of Clinical Investigation"},{"key":"1142_CR17","first-page":"54","volume":"1","author":"T Evron-Levy","year":"2022","unstructured":"Evron-Levy, T., Caspi, M., Wittenstein, A., Shorer-Arbel, Y., Shomron, O., Hirschberg, K., Kariv, R., & Rosin-Arbesfeld, R. (2022). Adenoma-Derived Organoids for Precision Therapy. Organoids., 1, 54\u201368.","journal-title":"Adenoma-Derived Organoids for Precision Therapy. Organoids."},{"key":"1142_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4161\/cbt.7.2.5296","volume":"7","author":"YR Lu","year":"2008","unstructured":"Lu, Y. R., Yuan, Y., Wang, X. J., et al. (2008). The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biology & Therapy, 7, 245\u2013251.","journal-title":"Cancer Biology & Therapy"},{"key":"1142_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mce.2018.01.024","volume":"473","author":"C Liu","year":"2018","unstructured":"Liu, C., Zhang, W., Peradze, N., et al. (2018). Mesenchymal stem cell (MSC)-mediated survival of insulin producing pancreatic \u03b2-cells during cellular stress involves signalling via Akt and ERK1\/2. Molecular and Cellular Endocrinology, 473, 235\u2013244.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"1142_CR20","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/1541-7786.MCR-19-0286","volume":"17","author":"C Chen","year":"2019","unstructured":"Chen, C., Notkins, A. L., & Lan, M. S. (2019). Insulinoma-associated-1: From neuroendocrine tumor marker to cancer therapeutics. Molecular Cancer Research, 17, 1597\u20131604.","journal-title":"Molecular Cancer Research"},{"key":"1142_CR21","first-page":"e22488","volume":"34","author":"A KaratugKacar","year":"2020","unstructured":"KaratugKacar, A. (2020). Indomethacin decreases insulin secretion by reducing KCa3.1 as a biomarker of pancreatic tumor and causes apoptotic cell death. Journal\u00a0of\u00a0Biochemical\u00a0and\u00a0Molecular Toxicology, 34, e22488.","journal-title":"Journal\u00a0of\u00a0Biochemical\u00a0and\u00a0Molecular Toxicology"},{"key":"1142_CR22","volume":"13","author":"RU Harvitkar","year":"2021","unstructured":"Harvitkar, R. U., Peri, H., Zallipalli, S. N., Joseph, S. J., Gattupalli, G. B., & Ansari, K. (2021). Non-cancer causes of death in patients with pancreatic adenocarcinoma: A surveillance, epidemiology, and end results (SEER)-based study. Cureus., 13, e20289.","journal-title":"Cureus."},{"key":"1142_CR23","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74, 12\u201349.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1142_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/or.2015.4339","volume":"35","author":"Q Lu","year":"2016","unstructured":"Lu, Q., Chen, H., Senkowski, C., Wang, J., Wang, X., Brower, S., Glasgow, W., Byck, D., Jiang, S. W., & Li, J. (2016). Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines. Oncology Reports, 35, 163\u2013170.","journal-title":"Oncology Reports"},{"key":"1142_CR25","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.3748\/wjg.v12.i41.6652","volume":"12","author":"XP He","year":"2006","unstructured":"He, X. P., Li, Z. S., Zhu, R. M., Tu, Z. X., Gao, J., Pan, X., Gong, Y. F., Jin, J., Man, X. H., Wu, H. Y., & Xu, A. F. (2006). Effects of recombinant human canstatin protein in the treatment of pancreatic cancer. World Journal of Gastroenterology, 12, 6652\u20136657.","journal-title":"World Journal of Gastroenterology"},{"key":"1142_CR26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fimmu.2018.01126","volume":"9","author":"A Kaur","year":"2018","unstructured":"Kaur, A., Riaz, M. S., Murugaiah, V., Varghese, P. M., Singh, S. K., & Kishore, U. (2018). A recombinant fragment of human surfactant protein D induces apoptosis in pancreatic cancer cell lines via Fas-mediated pathway. Frontiers in Immunology, 9, 1126.","journal-title":"Frontiers in Immunology"},{"key":"1142_CR27","doi-asserted-by":"publisher","first-page":"1106380","DOI":"10.3389\/fphys.2022.1106380","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., & Chen, M. (2022). Neuregulin 4 as a novel adipokine in energy metabolism. Frontiers in Physiology, 13, 1106380.","journal-title":"Frontiers in Physiology"},{"key":"1142_CR28","doi-asserted-by":"crossref","unstructured":"ZhangChen, P. Z., Kuang, H., et al. (2022). Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment. Cell Metabolism, 34, 1359\u20131376.e1357.","DOI":"10.1016\/j.cmet.2022.07.010"},{"key":"1142_CR29","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/cancers12071849","volume":"12","author":"D Brocco","year":"2020","unstructured":"Brocco, D., Florio, R., De Lellis, L., Veschi, S., Grassadonia, A., Tinari, N., & Cama, A. (2020). The role of dysfunctional adipose tissue in pancreatic cancer: A molecular perspective. Cancers (Basel), 12, 1849.","journal-title":"Cancers (Basel)"},{"key":"1142_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40779-022-00416-w","volume":"9","author":"X Huang","year":"2022","unstructured":"Huang, X., Zhang, G., Tang, T. Y., Gao, X., & Liang, T. B. (2022). Personalized pancreatic cancer therapy: From the perspective of mRNA vaccine. Military Medical Research, 9, 53.","journal-title":"Military Medical Research"},{"key":"1142_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-021-01310-0","volume":"20","author":"X Huang","year":"2021","unstructured":"Huang, X., Zhang, G., Tang, T., & Liang, T. (2021). Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. Molecular Cancer, 20, 44.","journal-title":"Molecular Cancer"},{"key":"1142_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691605","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen, Z., Zhang, S., Han, N., et al. (2021). A Neoantigen-Based peptide vaccine for patients with advanced pancreatic cancer refractory to standard treatment. Frontiers in Immunology, 12, 691605.","journal-title":"Frontiers in Immunology"},{"key":"1142_CR33","first-page":"641","volume":"19","author":"S Park","year":"2020","unstructured":"Park, S., Kim, D., Park, J. A., Kwon, H. J., & Lee, Y. (2020). Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells. Oncology Letters, 19, 641\u2013650.","journal-title":"Oncology Letters"},{"key":"1142_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/mab.2020.0011","volume":"39","author":"Y Kato","year":"2020","unstructured":"Kato, Y., Ohishi, T., Sano, M., Asano, T., Sayama, Y., Takei, J., Kawada, M., & Kaneko, M. K. (2020). H(2)Mab-19 anti-human epidermal growth factor receptor 2 monoclonal antibody therapy exerts antitumor activity in pancreatic cancer xenograft models. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 39, 61\u201365.","journal-title":"Monoclonal Antibodies in Immunodiagnosis and Immunotherapy"},{"key":"1142_CR35","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.1158\/1078-0432.CCR-13-0516","volume":"19","author":"K Yuan","year":"2013","unstructured":"Yuan, K., Sun, Y., Zhou, T., McDonald, J., & Chen, Y. (2013). PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. Clinical Cancer Research, 19, 4750\u20134759.","journal-title":"Clinical Cancer Research"},{"key":"1142_CR36","doi-asserted-by":"publisher","first-page":"15130","DOI":"10.1038\/ncomms15130","volume":"8","author":"Y Lei","year":"2017","unstructured":"Lei, Y., Tang, L., Xie, Y., Xianyu, Y., Zhang, L., Wang, P., Hamada, Y., Jiang, K., Zheng, W., & Jiang, X. (2017). Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer. Nature Communications, 8, 15130.","journal-title":"Nature Communications"},{"key":"1142_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ultrasmedbio.2019.09.016","volume":"46","author":"W Dong","year":"2020","unstructured":"Dong, W., Wu, P., Zhou, D., Huang, J., Qin, M., Yang, X., Wan, M., & Zong, Y. (2020). Ultrasound-mediated gene therapy of hepatocellular carcinoma using pre-microRNA plasmid-loaded nanodroplets. Ultrasound in Medicine and Biology, 46, 90\u2013107.","journal-title":"Ultrasound in Medicine and Biology"},{"key":"1142_CR38","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/jbm.b.34012","volume":"106","author":"B Matta-Domjan","year":"2018","unstructured":"Matta-Domjan, B., King, A., Totti, S., et al. (2018). Biophysical interactions between pancreatic cancer cells and pristine carbon nanotube substrates: Potential application for pancreatic cancer tissue engineering. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 106, 1637\u20131644.","journal-title":"Journal of Biomedical Materials Research. Part B, Applied Biomaterials"},{"key":"1142_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41563-021-01085-1","volume":"21","author":"CR Below","year":"2022","unstructured":"Below, C. R., Kelly, J., Brown, A., et al. (2022). A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids. Nature Materials, 21, 110\u2013119.","journal-title":"Nature Materials"},{"key":"1142_CR40","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3390\/ijms22084289","volume":"22","author":"J Pape","year":"2021","unstructured":"Pape, J., Stamati, K., Al, Hosni R., Uchegbu, I. F., Schatzlein, A. G., Loizidou, M., Emberton, M., & Cheema, U. (2021). Tissue-Engineering the fibrous pancreatic tumour stroma capsule in 3D tumouroids to demonstrate paclitaxel response. International Journal of Molecular Sciences, 22, 4289.","journal-title":"International Journal of Molecular Sciences"},{"key":"1142_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang, D. M., Pham, P. T., Bach, T. Q., et al. (2022). Stem cell-based therapy for human diseases. Signal Transduction and Targeted Therapy, 7, 272.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1142_CR42","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/cells9030563","volume":"9","author":"DT Chu","year":"2020","unstructured":"Chu, D. T., Nguyen, T. T., Tien, N. L. B., Tran, D. K., Jeong, J. H., Anh, P. G., Thanh, V. V., Truong, D. T., & Dinh, T. C. (2020). Recent progress of stem cell therapy in cancer treatment: Molecular mechanisms and potential applications. Cells, 9, 563.","journal-title":"Cells"},{"key":"1142_CR43","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.apsb.2019.11.013","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y., Zhou, W., Chen, X., Wang, Q., Li, C., Chen, Q., Zhang, Y., Lu, Y., Ding, X., & Jiang, C. (2020). Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Acta Pharmaceutica Sinica B, 10, 1563\u20131575.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1142_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/CJI.0000000000000164","volume":"40","author":"B Omazic","year":"2017","unstructured":"Omazic, B., Ayoglu, B., L\u00f6hr, M., et al. (2017). A preliminary report: Radical surgery and stem cell transplantation for the treatment of patients with pancreatic cancer. Journal of Immunotherapy, 40, 132\u2013139.","journal-title":"Journal of Immunotherapy"},{"key":"1142_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00709-023-01896-w","volume":"261","author":"I Hasoglu","year":"2024","unstructured":"Hasoglu, I., & Karatug, K. A. (2024). The therapeutic effects of exosomes the first time isolated from pancreatic islet-derived progenitor cells in the treatment of pancreatic cancer. Protoplasma, 261, 281\u2013291.","journal-title":"Protoplasma"},{"key":"1142_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13193-011-0042-1","volume":"2","author":"UK Ballehaninna","year":"2011","unstructured":"Ballehaninna, U. K., & Chamberlain, R. S. (2011). Serum CA 19-9 as a biomarker for pancreatic cancer-A comprehensive review. Indian Journal of Surgical Oncology, 2, 88\u2013100.","journal-title":"Indian Journal of Surgical Oncology"},{"key":"1142_CR47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ijc.22394","volume":"120","author":"EJ Lee","year":"2007","unstructured":"Lee, E. J., Gusev, Y., Jiang, J., Nuovo, G. J., Lerner, M. R., Frankel, W. L., Morgan, D. L., Postier, R. G., Brackett, D. J., & Schmittgen, T. D. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. International Journal of Cancer, 120, 1046\u20131054.","journal-title":"International Journal of Cancer"},{"key":"1142_CR48","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/jgh.13253","volume":"31","author":"J Namkung","year":"2016","unstructured":"Namkung, J., Kwon, W., Choi, Y., Yi, S. G., Han, S., Kang, M. J., Kim, S. W., Park, T., & Jang, J. Y. (2016). Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value. Journal of Gastroenterology and Hepatology, 31, 1160\u20131167.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"1142_CR49","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1186\/s12885-019-6284-y","volume":"19","author":"AZ Daoud","year":"2019","unstructured":"Daoud, A. Z., Mulholland, E. J., Cole, G., & McCarthy, H. O. (2019). MicroRNAs in Pancreatic cancer: Biomarkers, prognostic, and therapeutic modulators. BMC Cancer, 19, 1130.","journal-title":"BMC Cancer"},{"key":"1142_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3892\/br.2014.376","volume":"3","author":"W Wang","year":"2015","unstructured":"Wang, W., Zhang, L., Chen, L., et al. (2015). Serum carcinoembryonic antigen and carbohydrate antigen 19\u20139 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. Biomedical Reports, 3, 43\u201350.","journal-title":"Biomedical Reports"},{"key":"1142_CR51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbrc.2017.10.072","volume":"494","author":"S Jiang","year":"2017","unstructured":"Jiang, S., Zhu, L., Yang, J., Hu, L., Gu, J., Xing, X., Sun, Y., & Zhang, Z. (2017). Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer. Biochemical and Biophysical Research Communications, 494, 113\u2013119.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1142_CR52","doi-asserted-by":"publisher","first-page":"127718","DOI":"10.1016\/j.snb.2020.127718","volume":"308","author":"YP Sze","year":"2020","unstructured":"Sze, Y. P., Daizong, J., Yaru, L., Yanli, L., Yan, H., Qingmei, C., & Qingjun, L. (2020). Smartphone-based portable electrochemical biosensing system for detection of circulating microRNA-21 in saliva as a proof-of-concept. Sensors and Actuators B: Chemical, 308, 127718.","journal-title":"Sensors and Actuators B: Chemical"},{"key":"1142_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12876-021-01906-2","volume":"21","author":"CL Li","year":"2021","unstructured":"Li, C. L., Jiang, M., Pan, C. Q., Li, J., & Xu, L. G. (2021). The global, regional, and national burden of acute pancreatitis in 204 countries and territories, 1990\u20132019. BMC Gastroenterology, 21, 332.","journal-title":"BMC Gastroenterology"},{"key":"1142_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mce.2015.12.002","volume":"422","author":"LT Yu","year":"2016","unstructured":"Yu, L. T., Yang, M. Q., Liu, J. L., Alfred, M. O., Li, X., Zhang, X. Q., Zhang, J., Wu, M. Y., Wang, M., & Luo, C. (2016). Recombinant Reg3\u03b1 protein protects against experimental acute pancreatitis in mice. Molecular and Cellular Endocrinology, 422, 150\u2013159.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"1142_CR55","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/MCG.0000000000001314","volume":"55","author":"E Almon","year":"2021","unstructured":"Almon, E., Shaaltiel, Y., Sbeit, W., et al. (2021). Novel orally administered recombinant anti-tnf alpha fusion protein for the treatment of ulcerative colitis: Results from a phase 2a clinical trial. Journal of Clinical Gastroenterology, 55, 134\u2013140.","journal-title":"Journal of Clinical Gastroenterology"},{"key":"1142_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2478\/rir-2023-0020","volume":"4","author":"PS Ram","year":"2023","unstructured":"Ram, P. S., David, S. B., Satendra, S. S., & Bevra, H. H. (2023). Peptide-based immunotherapy in lupus: Where are we now? Rheumatology and Immunology Research, 4, 139\u2013149.","journal-title":"Rheumatology and Immunology Research"},{"key":"1142_CR57","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/ibd\/izy142","volume":"24","author":"Q Guan","year":"2018","unstructured":"Guan, Q., Weiss, C. R., Wang, S., Qing, G., Yang, X., Warrington, R. J., Bernstein, C. N., & Peng, Z. (2018). Reversing ongoing chronic intestinal inflammation and fibrosis by sustained block of IL-12 and IL-23 using a vaccine in mice. Inflammatory Bowel Diseases, 24, 1941\u20131952.","journal-title":"Inflammatory Bowel Diseases"},{"key":"1142_CR58","doi-asserted-by":"publisher","first-page":"Fso405","DOI":"10.2144\/fsoa-2018-0125","volume":"5","author":"Q Guan","year":"2019","unstructured":"Guan, Q., Warrington, R., Moreno, S., Qing, G., Weiss, C., & Peng, Z. (2019). Sustained suppression of IL-18 by employing a vaccine ameliorates intestinal inflammation in TNBS-induced murine colitis. Future Science OA, 5, Fso405.","journal-title":"Future Science OA"},{"key":"1142_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.intimp.2016.03.013","volume":"35","author":"X Zhuang","year":"2016","unstructured":"Zhuang, X., Shen, J., Jia, Z., Wu, A., Xu, T., Shi, Y., & Xu, C. (2016). Anti-B7-H3 monoclonal antibody ameliorates the damage of acute experimental pancreatitis by attenuating the inflammatory response. International Immunopharmacology, 35, 1\u20136.","journal-title":"International Immunopharmacology"},{"key":"1142_CR60","doi-asserted-by":"publisher","first-page":"205873842110212","DOI":"10.1177\/20587384211021215","volume":"35","author":"T Khoury","year":"2021","unstructured":"Khoury, T., Rotnemer-Golinkin, D., Zolotarev, L., & Ilan, Y. (2021). Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach. International Journal of Immunopathology and Pharmacology, 35, 20587384211021216.","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"1142_CR61","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1744-8069-4-8","volume":"4","author":"H Yang","year":"2008","unstructured":"Yang, H., McNearney, T. A., Chu, R., Lu, Y., Ren, Y., Yeomans, D. C., Wilson, S. P., & Westlund, K. N. (2008). Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Molecular Pain, 4, 8.","journal-title":"Molecular Pain"},{"key":"1142_CR62","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/sj.mt.6300228","volume":"15","author":"Y Lu","year":"2007","unstructured":"Lu, Y., McNearney, T. A., Lin, W., Wilson, S. P., Yeomans, D. C., & Westlund, K. N. (2007). Treatment of inflamed pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae. Molecular Therapy, 15, 1812\u20131819.","journal-title":"Molecular Therapy"},{"key":"1142_CR63","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-019-1260-7","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye, Z., Lu, W., Liang, L., et al. (2019). Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice. Stem Cell Research & Therapy, 10, 149.","journal-title":"Stem Cell Research & Therapy"},{"key":"1142_CR64","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.3748\/wjg.v25.i30.4074","volume":"25","author":"MM Yeh","year":"2019","unstructured":"Yeh, M. M., Bosch, D. E., & Daoud, S. S. (2019). Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases. World Journal of Gastroenterology, 25, 4074\u20134091.","journal-title":"World Journal of Gastroenterology"},{"key":"1142_CR65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12951-023-02200-x","volume":"21","author":"L Liu","year":"2023","unstructured":"Liu, L., Zhang, Y., Li, X., & Deng, J. (2023). Microenvironment of pancreatic inflammation: Calling for nanotechnology for diagnosis and treatment. Journal of Nanobiotechnology, 21, 443.","journal-title":"Journal of Nanobiotechnology"},{"key":"1142_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13036-019-0163-6","volume":"13","author":"X Meng","year":"2019","unstructured":"Meng, X., Zheng, M., Yu, M., Bai, W., Zuo, L., Bu, X., Liu, Y., Xia, L., Hu, J., Liu, L., & Li, J. (2019). Transplantation of CRISPRa system engineered IL10-overexpressing bone marrow-derived mesenchymal stem cells for the treatment of myocardial infarction in diabetic mice. Journal of Biological Engineering, 13, 49.","journal-title":"Journal of Biological Engineering"},{"key":"1142_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5152\/tjg.2020.19143","volume":"31","author":"H Chela","year":"2020","unstructured":"Chela, H., Romana, B. S., Madabattula, M., Albarrak, A. A., Yousef, M. H., Samiullah, S., & Tahan, V. (2020). Stem cell therapy: A potential for the perils of pancreatitis. The Turkish Journal of Gastroenterology, 31, 415\u2013424.","journal-title":"The Turkish Journal of Gastroenterology"},{"key":"1142_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-017-1363-9","volume":"53","author":"K Kawakubo","year":"2018","unstructured":"Kawakubo, K., Ohnishi, S., Kuwatani, M., & Sakamoto, N. (2018). Mesenchymal stem cell therapy for acute and chronic pancreatitis. Journal of Gastroenterology, 53, 1\u20135.","journal-title":"Journal of Gastroenterology"},{"key":"1142_CR69","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.ymthe.2017.06.016","volume":"25","author":"Z Sun","year":"2017","unstructured":"Sun, Z., Gou, W., Kim, D. S., Dong, X., Strange, C., Tan, Y., Adams, D. B., & Wang, H. (2017). Adipose stem cell therapy mitigates chronic pancreatitis via differentiation into acinar-like cells in mice. Molecular Therapy, 25, 2490\u20132501.","journal-title":"Molecular Therapy"},{"key":"1142_CR70","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1080\/21655979.2021.1928441","volume":"12","author":"L Kong","year":"2021","unstructured":"Kong, L., Xu, X., Zhang, H., Zhou, Y., Huang, H., Chen, B., & Zhou, Z. (2021). Human umbilical cord-derived mesenchymal stem cells improve chronic pancreatitis in rats via the AKT-mTOR-S6K1 signaling pathway. Bioengineered, 12, 1986\u20131996.","journal-title":"Bioengineered"},{"key":"1142_CR71","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1023\/A:1005525329939","volume":"45","author":"R Pezzilli","year":"2000","unstructured":"Pezzilli, R., Melzid\u2019Eril, G. V., Morselli-Labate, A. M., Merlini, G., Barakat, B., & Bosoni, T. (2000). Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Digestive Diseases and Sciences, 45, 1072\u20131078.","journal-title":"Digestive Diseases and Sciences"},{"key":"1142_CR72","unstructured":"Magliano, D.J., Boyko E.J., committee I.D.F.D.A.t.e.s. (2021). IDF diabetes atlas. International Diabetes Federation."},{"key":"1142_CR73","doi-asserted-by":"publisher","first-page":"35640","DOI":"10.1038\/srep35640","volume":"6","author":"C Luo","year":"2016","unstructured":"Luo, C., Yu, L. T., Yang, M. Q., Li, X., Zhang, Z. Y., Alfred, M. O., Liu, J. L., & Wang, M. (2016). Recombinant Reg3\u03b2 protein protects against streptozotocin-induced \u03b2-cell damage and diabetes. Science and Reports, 6, 35640.","journal-title":"Science and Reports"},{"key":"1142_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103202","volume":"63","author":"Q Pan","year":"2021","unstructured":"Pan, Q., Lin, S., Li, Y., et al. (2021). A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis. eBioMedicine, 63, 103202.","journal-title":"eBioMedicine"},{"key":"1142_CR75","first-page":"161","volume":"35","author":"M Moghtaderi","year":"2021","unstructured":"Moghtaderi, M., Zarei, P., Shakerian, B., Babaei, M., Mostafavi, A., & Modaressi, M. (2021). The non-significant benefit of BCG vaccination for the treatment of iranian patients with type 1 diabetes up to 48 weeks: A controversial result. Medical Journal of the Islamic Republic of Iran, 35, 161.","journal-title":"Medical Journal of the Islamic Republic of Iran"},{"key":"1142_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070056","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Gao, W., Yang, X., Kang, J., Zhang, Y., Guo, Q., Hu, Y., Xia, G., & Kang, Y. (2013). Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment. PLoS ONE, 8, e70056.","journal-title":"PLoS ONE"},{"key":"1142_CR77","doi-asserted-by":"publisher","first-page":"e0150018","DOI":"10.1371\/journal.pone.0150018","volume":"11","author":"EA McKie","year":"2016","unstructured":"McKie, E. A., Reid, J. L., Mistry, P. C., DeWall, S. L., Abberley, L., Ambery, P. D., & Gil-Extremera, B. (2016). A study to investigate the efficacy and safety of an anti-interleukin-18 monoclonal antibody in the treatment of type 2 diabetes mellitus. PLoS ONE, 11, e0150018.","journal-title":"PLoS ONE"},{"key":"1142_CR78","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/2211-5463.13349","volume":"12","author":"H Li","year":"2022","unstructured":"Li, H., He, X., Wen, S., Yang, L., Chen, Q., Li, Y., Huang, S., Huang, X., Wan, F., & He, M. (2022). Optimised expression and purification of RBP4 and preparation of anti-RBP4 monoclonal antibody. FEBS Open Bio, 12, 430\u2013442.","journal-title":"FEBS Open Bio"},{"key":"1142_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2337\/db19-1241","volume":"70","author":"R Huang","year":"2021","unstructured":"Huang, R., Bai, X., Li, X., Wang, X., & Zhao, L. (2021). Retinol-binding protein 4 activates STRA6, provoking pancreatic \u03b2-cell dysfunction in type 2 diabetes. Diabetes, 70, 449\u2013463.","journal-title":"Diabetes"},{"key":"1142_CR80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/sj.gt.3302836","volume":"14","author":"M Kumar","year":"2007","unstructured":"Kumar, M., Hunag, Y., Glinka, Y., Prud\u2019homme, G. J., & Wang, Q. (2007). Gene therapy of diabetes using a novel GLP-1\/IgG1-Fc fusion construct normalizes glucose levels in db\/db mice. Gene Therapy, 14, 162\u2013172.","journal-title":"Gene Therapy"},{"key":"1142_CR81","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1038\/s41467-019-12472-3","volume":"10","author":"F Lebreton","year":"2019","unstructured":"Lebreton, F., Lavallard, V., Bellofatto, K., et al. (2019). Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes. Nature Communications, 10, 4491.","journal-title":"Nature Communications"},{"key":"1142_CR82","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.3389\/ti.2021.10214","volume":"35","author":"CH Wassmer","year":"2021","unstructured":"Wassmer, C. H., Lebreton, F., Bellofatto, K., et al. (2021). Bio-engineering of pre-vascularized islet organoids for the treatment of type 1 diabetes. Transplant International, 35, 10214.","journal-title":"Transplant International"},{"key":"1142_CR83","doi-asserted-by":"crossref","unstructured":"Kimura, M., Iguchi, T., Iwasawa, K., et al. (2022). En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH. Cell, 185, 4216\u20134232.e4216.","DOI":"10.1016\/j.cell.2022.09.031"},{"key":"1142_CR84","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1021\/acsnano.7b07643","volume":"12","author":"Y Sun","year":"2018","unstructured":"Sun, Y., Shi, H., Yin, S., et al. (2018). Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving \u03b2-cell destruction. ACS Nano, 12, 7613\u20137628.","journal-title":"ACS Nano"},{"key":"1142_CR85","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","volume":"13","author":"S Tian","year":"2022","unstructured":"Tian, S., Zhou, X., Zhang, M., et al. (2022). Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages. Stem Cell Research & Therapy, 13, 330.","journal-title":"Stem Cell Research & Therapy"},{"key":"1142_CR86","doi-asserted-by":"publisher","first-page":"100958","DOI":"10.1016\/j.molmet.2020.02.001","volume":"35","author":"C Dumayne","year":"2020","unstructured":"Dumayne, C., Tarussio, D., Sanchez-Archidona, A. R., Picard, A., Basco, D., Berney, X. P., Ibberson, M., & Thorens, B. (2020). Klf6 protects \u03b2-cells against insulin resistance-induced dedifferentiation. Mol Metab., 35, 100958.","journal-title":"Mol Metab."},{"key":"1142_CR87","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/jcm10020262","volume":"10","author":"LI Coman","year":"2021","unstructured":"Coman, L. I., Coman, O. A., B\u0103d\u0103r\u0103u, I. A., P\u0103unescu, H., & Cioc\u00eerlan, M. (2021). Association between liver cirrhosis and diabetes mellitus: A review on hepatic outcomes. Journal of Clinical Medicine, 10, 262.","journal-title":"Journal of Clinical Medicine"},{"key":"1142_CR88","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s00125-018-4559-5","volume":"61","author":"AJ Lakhter","year":"2018","unstructured":"Lakhter, A. J., Pratt, R. E., Moore, R. E., Doucette, K. K., Maier, B. F., DiMeglio, L. A., & Sims, E. K. (2018). Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes. Diabetologia, 61, 1124\u20131134.","journal-title":"Diabetologia"},{"key":"1142_CR89","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.pan.2020.04.020","volume":"20","author":"S Boga","year":"2020","unstructured":"Boga, S., Koksal, A. R., Sen, \u0130, Kurul, Y. M., Yilmaz Ozguven, M. B., Serin, E., Erturk, S. M., Alkim, H., & Alkim, C. (2020). Liver and pancreas: \u2019Castor and Pollux\u2019 regarding the relationship between hepatic steatosis and pancreas exocrine insufficiency. Pancreatology, 20, 880\u2013886.","journal-title":"Pancreatology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01142-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01142-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01142-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T06:13:57Z","timestamp":1742710437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01142-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01142-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"27 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}